The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Agree Valju.
Has not just affected the share price. We have not been able to develop the company and look at mergers or acquisitions without having to reserve precious cash.
How much has this cost the company ?
Very interesting article on Radio 4 Today programme.
Start time 8.16.52s
Spoke about how swab testing took 2 days to get results, a nurse said there was a 10 minute test in Canada, but doubts were raised about accuracy and a doctors take on mass testing.
Do we know how accurate out LFT is ?
I don't share your positivity Valju and that is not called for.
We've seen it far too many times.
A 10p rise on fresh air doesn't float my boat.
We have every right to be negative about a company we are all heavily committed to, that tells us $od all.
Let's have some direction and concrete news from the company.
And I can no longer afford Gin.
Orangutan73 : We only open to a hostile takeover if they are able to view the DHSC dispute details and the company with it's NDA would not ( should not) disclose this to a third party.
This makes a hostile takeover very unlikely.
crl: The sp is low because investors want to see forthcoming sales forecast and contracts won.
I'm afraid money in the bank stagnating will do nothing to improve it.
A contract in Canada and Poland with no details given at the last presentation won't cut it.